ARCHIVES

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

In Brief: ONS Lectures Announced; Brennan To Retire As Michigan Cancer Foundation President

April 19, 1991